GB0307869D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB0307869D0
GB0307869D0 GBGB0307869.8A GB0307869A GB0307869D0 GB 0307869 D0 GB0307869 D0 GB 0307869D0 GB 0307869 A GB0307869 A GB 0307869A GB 0307869 D0 GB0307869 D0 GB 0307869D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0307869.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0307869.8A priority Critical patent/GB0307869D0/en
Publication of GB0307869D0 publication Critical patent/GB0307869D0/en
Priority to US10/550,360 priority patent/US20060110448A1/en
Priority to BRPI0409207-4A priority patent/BRPI0409207A/pt
Priority to PCT/EP2004/003515 priority patent/WO2004087144A1/en
Priority to CNA2004800092493A priority patent/CN1771036A/zh
Priority to EP04725354A priority patent/EP1613317A1/en
Priority to CA002521261A priority patent/CA2521261A1/en
Priority to YUP-2005/0752A priority patent/RS20050752A/sr
Priority to MXPA05010709A priority patent/MXPA05010709A/es
Priority to AU2004226823A priority patent/AU2004226823A1/en
Priority to JP2006504968A priority patent/JP2006522061A/ja
Priority to IS8106A priority patent/IS8106A/is
Priority to NO20055137A priority patent/NO20055137L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0307869.8A 2003-04-04 2003-04-04 Pharmaceutical composition Ceased GB0307869D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB0307869.8A GB0307869D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
US10/550,360 US20060110448A1 (en) 2003-04-04 2004-02-04 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases
JP2006504968A JP2006522061A (ja) 2003-04-04 2004-04-02 皮膚疾患の処置のための、マクロライドおよび局所麻酔薬の組合せ
CA002521261A CA2521261A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases
PCT/EP2004/003515 WO2004087144A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases
CNA2004800092493A CN1771036A (zh) 2003-04-04 2004-04-02 用于治疗皮肤病学疾病的大环内酯和局部麻醉剂的组合
EP04725354A EP1613317A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases
BRPI0409207-4A BRPI0409207A (pt) 2003-04-04 2004-04-02 combinação de um macrolìdeo e um anestésico local para o tratamento de doenças dermatológicas
YUP-2005/0752A RS20050752A (sr) 2003-04-04 2004-04-02 Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja
MXPA05010709A MXPA05010709A (es) 2003-04-04 2004-04-02 Combinacion de un macrolido y un anestesico local para el tratamiento de enfermedades dermatologicas.
AU2004226823A AU2004226823A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases
IS8106A IS8106A (is) 2003-04-04 2005-10-31 Samsetning makrólíðs og staðdeyfingarlyfs til að meðhöndla húðsjúkdóma
NO20055137A NO20055137L (no) 2003-04-04 2005-11-02 Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0307869.8A GB0307869D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB0307869D0 true GB0307869D0 (en) 2003-05-14

Family

ID=9956231

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0307869.8A Ceased GB0307869D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition

Country Status (13)

Country Link
US (1) US20060110448A1 (https=)
EP (1) EP1613317A1 (https=)
JP (1) JP2006522061A (https=)
CN (1) CN1771036A (https=)
AU (1) AU2004226823A1 (https=)
BR (1) BRPI0409207A (https=)
CA (1) CA2521261A1 (https=)
GB (1) GB0307869D0 (https=)
IS (1) IS8106A (https=)
MX (1) MXPA05010709A (https=)
NO (1) NO20055137L (https=)
RS (1) RS20050752A (https=)
WO (1) WO2004087144A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
KR102141441B1 (ko) * 2018-06-28 2020-08-05 이환석 무출혈 무통필름
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB766245A (en) * 1954-09-03 1957-01-16 Lilly Co Eli Therapeutic preparations containing erythromycin
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
CN100335063C (zh) * 1994-10-26 2007-09-05 诺瓦蒂斯有限公司 药物组合物
CN1158258A (zh) * 1996-12-11 1997-09-03 李志辉 秦云创伤外用药
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6120792A (en) * 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
JP2001288086A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 皮膚疾患の治療用又は予防用外用剤
JP2001288085A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 乾癬の治療用又は予防用外用剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
WO2002062353A1 (en) * 2001-02-05 2002-08-15 Marie Madeline Wharton Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof
RU2195279C1 (ru) * 2001-07-10 2002-12-27 Тульский государственный университет Способ лечения отморожений
CN1189193C (zh) * 2001-09-10 2005-02-16 黄家伶 烧伤药膏
CN1197576C (zh) * 2002-08-30 2005-04-20 孙万一 治疗性病疣的药物及其制备方法

Also Published As

Publication number Publication date
CA2521261A1 (en) 2004-10-14
CN1771036A (zh) 2006-05-10
IS8106A (is) 2005-10-31
JP2006522061A (ja) 2006-09-28
AU2004226823A1 (en) 2004-10-14
NO20055137L (no) 2006-01-04
US20060110448A1 (en) 2006-05-25
RS20050752A (sr) 2007-11-15
NO20055137D0 (no) 2005-11-02
MXPA05010709A (es) 2005-12-12
BRPI0409207A (pt) 2006-03-28
WO2004087144A1 (en) 2004-10-14
EP1613317A1 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
HU0301154D0 (en) Pharmaceutical composition
IL165878A0 (en) Pharmaceutical composition
GB0300531D0 (en) Pharmaceutical compositions
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) PHARMACEUTICAL COMPOSITION
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
ZA200605080B (en) Pharmaceutical compositions
GB0300885D0 (en) Pharmaceutical composition
EP1600445A4 (en) CURATIVE PREPARATION
EP1655029A4 (en) MEDICINAL COMPOSITIONS
GB0306933D0 (en) Pharmaceutical composition
GB0307869D0 (en) Pharmaceutical composition
GB0305579D0 (en) Pharmaceutical compositions
GB0307864D0 (en) Pharmaceutical composition
GB0307867D0 (en) Pharmaceutical composition
GB0307862D0 (en) Pharmaceutical composition
GB0217703D0 (en) Pharmaceutical composition
GB0307865D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)